Arthur V. Miller

Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase.

L. Hamann, P. Stein, D. Green, 2004, Bioorganic & medicinal chemistry letters.

N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase.

K. J. Yost, Hsinglin Lan, L. Hamann, 2004, Bioorganic & medicinal chemistry letters.

2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.

David S. Taylor, David S Nirschl, C. Weigelt, 2008, Bioorganic & medicinal chemistry letters.

Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists

R. Moquin, S. Moreland, K. Dickinson, 1992 .

Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.

David S. Nirschl, David S. Taylor, David S Nirschl, 2012, Journal of medicinal chemistry.

Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3.

David S. Nirschl, Jonathan Lippy, John S Tokarski, 2011, Bioorganic & medicinal chemistry letters.

Quinoxaline N‐Oxide Containing Potent Angiotensin II Receptor Antagonists: Synthesis, Biological Properties, and Structure‐Activity Relationships.

T. Waldron, S. Moreland, K. Dickinson, 1993 .

Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.

S. Chong, J. Hunt, Soong-Hoon Kim, 2000, Journal of medicinal chemistry.

Application of lean manufacturing concepts to drug discovery: rapid analogue library synthesis.

Harold N Weller, John G Houston, David S. Nirschl, 2006, Journal of combinatorial chemistry.